Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys and ribavirin for 16 vs 24 weeks in genotype 2 chronic hepatitis C
NCT01056172Phase 4Unknown
- Sponsor
- Pusan National University Hospital
- Start
- Jan 2010
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by Pusan National University Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01056172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056172.